|
|
TTD Drug ID:
DNC010715
Drug
Information |
Name | N-(2,6-Dimethylphenyl)-N'-hydroxyoctanediamide | Indication | Not Available | Experimental | Structure |
Click to save drug structure in 3D MOL format
Click to save drug structure in 2D MOL format
| InChI | 1S/C14H20N2O3/c1-10-6-5-7-11(2)14(10)15-12(17)8-3-4-9-13(18)16-19 /h5-7,19H,3-4,8-9H2,1-2H3,(H,15,17)(H,16,18) | InChIKey | XTVDLARVBFOJBV-UHFFFAOYSA-N | Canonical SMILES | CC1=C(C(=CC=C1)C)NC(=O)CCCCC(=O)NO | Target | Histone deacetylase 1 |  | Inhibitor | [1] | Histone deacetylase 3 |  | Inhibitor | [1] | Ref 1 | J Med Chem. 2010 Mar 11;53(5):1937-50.Biological and biophysical properties of the histone deacetylase inhibitor suberoylanilide hydroxamic acid are affected by the presence of short alkyl groups on the phenyl ring. To Reference |
Welcome
to sign our Guestbook.
If you
find any error in data or bug in web service, please kindly report it
to Dr.
Zhu.
Dr.
Chen Yuzong
Deputy Director of Center
for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore
All rights reserved.
|